Literature DB >> 22734902

Suppression of neurokinin-1 receptor in trigeminal ganglia attenuates central sensitization following inflammation.

Mamoru Takeda1, Masayuki Takahashi, Shigeji Matsumoto.   

Abstract

This study examined whether local application of a neurokinin-1 (NK1) receptor antagonist into the trigeminal ganglia (TRGs) modulates hyperexcitability of trigeminal spinal nucleus caudalis (SpVc) wide-dynamic range (WDR) neuron activity innervating both the temporomandibular joint (TMJ) region and facial skin following TMJ inflammation. Extracellular single unit recording combined with multibarrel electrodes was used. TMJ inflammation was induced by the injection of complete Freund's adjuvant (CFA). WDR neurons responding to electrical stimuli of the TMJ region and facial skin were recorded from the SpVc in anesthetized rats. The spontaneous and mechanical stimulation-induced discharge frequencies of WDR neurons were significantly larger in inflamed rats than in control rats. The spontaneous WDR activities were current-dependently decreased by local iontophoretic application of an NK1 receptor antagonist into the TRGs after 1 and 2 days of inflammation. The firing frequency of WDR neurons and threshold evoked by mechanical stimulation of facial skin returned to control levels by application of the NK1 receptor antagonist into TRGs after 1 day, but not 2 days, of inflammation. These results suggest that in the early stages of inflammation suppression of the NK1 receptor mechanism in TRGs may prevent central sensitization of SpVc nociceptive neurons.
© 2012 Peripheral Nerve Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734902     DOI: 10.1111/j.1529-8027.2012.00404.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  14 in total

1.  The role of the trigeminal sensory nuclear complex in the pathophysiology of craniocervical dystonia.

Authors:  Lynley Bradnam; Christine Barry
Journal:  J Neurosci       Date:  2013-11-20       Impact factor: 6.167

2.  Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers.

Authors:  Bruno Pradier; Hye Bin Shin; Duk Soo Kim; Robyn St Laurent; Diane Lipscombe; Julie A Kauer
Journal:  J Neurosci       Date:  2018-07-27       Impact factor: 6.167

3.  Current understanding of trigeminal ganglion structure and function in headache.

Authors:  Karl Messlinger; Andrew F Russo
Journal:  Cephalalgia       Date:  2018-07-10       Impact factor: 6.292

Review 4.  Status of peripheral sodium channel blockers for non-addictive pain treatment.

Authors:  Matthew Alsaloum; Grant P Higerd; Philip R Effraim; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2020-10-27       Impact factor: 42.937

5.  Phytochemical quercetin alleviates hyperexcitability of trigeminal nociceptive neurons associated with inflammatory hyperalgesia comparable to NSAIDs.

Authors:  Haruka Itou; Ryou Toyota; Mamoru Takeda
Journal:  Mol Pain       Date:  2022-04       Impact factor: 3.370

6.  Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI).

Authors:  Golam Mustafa; Jiamei Hou; Shigeharu Tsuda; Rachel Nelson; Ankita Sinharoy; Zachary Wilkie; Rahul Pandey; Robert M Caudle; John K Neubert; Floyd J Thompson; Prodip Bose
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

7.  Brain-derived neurotrophic factor enhances the excitability of small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone following masseter muscle inflammation.

Authors:  Mamoru Takeda; Masayuki Takahashi; Junichi Kitagawa; Takuya Kanazawa; Masanori Nasu; Shigeji Matsumoto
Journal:  Mol Pain       Date:  2013-09-30       Impact factor: 3.395

8.  The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor.

Authors:  Shiori Takehana; Yoshiko Kubota; Nobuo Uotsu; Kei Yui; Koichi Iwata; Yoshihito Shimazu; Mamoru Takeda
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

9.  Dietary constituent, decanoic acid suppresses the excitability of nociceptive trigeminal neuronal activity associated with hypoalgesia via muscarinic M2 receptor signaling.

Authors:  Yuna Noguchi; Nichiwa Matsuzawa; Youichi Akama; Kenta Sekiguchi; Shiori Takehana; Yoshihito Shimazu; Mamoru Takeda
Journal:  Mol Pain       Date:  2017 Jan-Dec       Impact factor: 3.395

10.  Resveratrol attenuates inflammation-induced hyperexcitability of trigeminal spinal nucleus caudalis neurons associated with hyperalgesia in rats.

Authors:  Kenta Sekiguchi; Shiori Takehana; Eri Shibuya; Nichiwa Matsuzawa; Shiori Hidaka; Yurie Kanai; Maki Inoue; Yoshiko Kubota; Yoshihito Shimazu; Mamoru Takeda
Journal:  Mol Pain       Date:  2016-04-11       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.